YWHAQ and cancer: These small molecule inhibitors of 14-3-3 proteins exhibit anti-cancer activity in cell-based assays but are limited by their specificity, ability to penetrate cells and also the need for high concentrations to effectively compete with abundant endogenous 14-3-3-binding proteins.